PDE4A and frontotemporal dementia: It will be interesting to study a synergistic effect of Forskolin and PDE4 inhibitors on the pathophysiology of ALS-FTD which might be effective in much lower doses pharmacologically and well tolerated treatment option without much side effects for this challenging neurodegenerative disorder.